Founded in 2008, Matrix Partners China is one of the leading venture capital firms focused on early stage and early growth deals in China, now managing over 50 billion RMB.
Matrix Partners China mainly invests in new economy, deep technology, industrial digitalization, healthcare, frontier technology and new consumer brands. The firm has invested in more than 700 companies, including XPeng, Li-Auto, Futu Securities, Guazi，Eleme, Youzan, Ronbaymat, Xgimi, Momo, PingCap, Peijia Medical, Career International, Chemclin, Beisen, Lexin, ZiHaiGuo, ITcast, METAX, Simplelove, SemiDrive, MegaRobo, Akrostar Technology, X-EPIC, Bota Bio, Advaccine and so on.
Matrix Partners China has over 40 investment professionals with deep sector knowledge. The firm also established one of the largest portfolio management teams in the market. Over 80 professionals formed 10 different functions including strategy and operation consulting, recruiting, and healthcare services, etc., to provide value added services to entrepreneurs.